151 related articles for article (PubMed ID: 35328043)
1. Alternative Promoters of
Zhawar VK; Kandpal RP; Athwal RS
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328043
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
Vaidya H; Rumph C; Katula KS
PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter.
Han H; Cortez CC; Yang X; Nichols PW; Jones PA; Liang G
Hum Mol Genet; 2011 Nov; 20(22):4299-310. PubMed ID: 21835883
[TBL] [Abstract][Full Text] [Related]
7. [Effects of methylation status of CpG islands on results of luciferase reporter assay].
Zhang BZ; Deng DJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):601-6. PubMed ID: 19954072
[TBL] [Abstract][Full Text] [Related]
8. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
9. CpG dinucleotide-specific hypermethylation of the TNS3 gene promoter in human renal cell carcinoma.
Carter JA; Górecki DC; Mein CA; Ljungberg B; Hafizi S
Epigenetics; 2013 Jul; 8(7):739-47. PubMed ID: 23803643
[TBL] [Abstract][Full Text] [Related]
10. Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor.
Deng G; Song GA; Pong E; Sleisenger M; Kim YS
Cancer Res; 2004 Apr; 64(8):2692-8. PubMed ID: 15087381
[TBL] [Abstract][Full Text] [Related]
11. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
Bhakat KK; Mitra S
Carcinogenesis; 2003 Aug; 24(8):1337-45. PubMed ID: 12807730
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector.
Klug M; Rehli M
Epigenetics; 2006; 1(3):127-30. PubMed ID: 17965610
[TBL] [Abstract][Full Text] [Related]
13. Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells.
Bakker J; Lin X; Nelson WG
J Biol Chem; 2002 Jun; 277(25):22573-80. PubMed ID: 11960994
[TBL] [Abstract][Full Text] [Related]
14. Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression.
Ghoshal K; Majumder S; Datta J; Motiwala T; Bai S; Sharma SM; Frankel W; Jacob ST
J Biol Chem; 2004 Feb; 279(8):6783-93. PubMed ID: 14610093
[TBL] [Abstract][Full Text] [Related]
15. Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers.
Palmisano WA; Crume KP; Grimes MJ; Winters SA; Toyota M; Esteller M; Joste N; Baylin SB; Belinsky SA
Cancer Res; 2003 Aug; 63(15):4620-5. PubMed ID: 12907641
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma.
To KK; Zhan Z; Bates SE
Mol Cell Biol; 2006 Nov; 26(22):8572-85. PubMed ID: 16954373
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
19. Novel spliced variants of ionotropic glutamate receptor GluR6 in normal human fibroblast and brain cells are transcribed by tissue specific promoters.
Zhawar VK; Kaur G; deRiel JK; Kaur GP; Kandpal RP; Athwal RS
Gene; 2010 Jul; 459(1-2):1-10. PubMed ID: 20230879
[TBL] [Abstract][Full Text] [Related]
20. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
Kao RH; Huang LC; Hsu YH
Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]